Observations placeholder
Study of possible correlation between HALLUCINATION and DIMEMORFAN PHOSPHATE
Identifier
018246
Type of Spiritual Experience
Background
A description of the experience
Study of possible correlation between HALLUCINATION and DIMEMORFAN PHOSPHATE
About this FactMed analysis covering adverse side effect reports of DIMEMORFAN PHOSPHATE patients who developed HALLUCINATION.
FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking DIMEMORFAN PHOSPHATE reported HALLUCINATION to the FDA. A total of 55 DIMEMORFAN PHOSPHATE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.